SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 4, 2012
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
11 Studebaker, Irvine, CA
(Address of principal executive offices)
Registrant's telephone number, including area code: (949) 595-7200
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 4, 2012, Mr. Robert J. Krist, Chief Financial Officer of Endologix, Inc. (the “Company”), notified the Board of Directors of the Company that he will retire from the Company effective upon completion of the transition of his duties and responsibilities to his successor as Chief Financial Officer. It is currently the intent of Mr. Krist and the Company that Mr. Krist will continue in his present position to assist in making a smooth transition to his successor. Mr. Krist will also be available in the future on a consulting basis as needed. The Board of Directors has commenced a search for a new Chief Financial Officer to replace Mr. Krist.
A press release announcing Mr. Krist's retirement was issued on December 4, 2012, and a copy is filed as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
Press release issued December 4, 2012.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 4, 2012
/s/ John McDermott
Chief Executive Officer